The Uromigos

The Uromigos podcast, hosted by Tom Powles, professor of genitourinary oncology at Barts Cancer Centre, and Brian Rini, Ingram Professor of Medicine at Vanderbilt-Ingram Cancer Center, aims to broadcast the latest developments in GU cancer. Each episode features fascinating discussions with leading experts from around the world and dives into the data and clinical news relevant to the care of GU oncology patients. In their “Legends of GU Oncology” series, the podcasting duo focus on the founders of the field.

Articles by The Uromigos

The UromigosThe Uromigos | June 1, 2023
Drs. David McDermott and Meredith Regan discuss statistics in clinical trials and upcoming RCC presentations at ASCO 2023.
Listen Now
The UromigosThe Uromigos | June 1, 2023
We chat with Christopher Sweeney about the upcoming ASCO 2023 conference and what presentations to look out for.
The UromigosThe Uromigos | May 23, 2023
Professor Nick James discusses the success of the STAMPEDE trial on the use of abiraterone in patients with prostate cancer.
The UromigosThe Uromigos | May 16, 2023
Dr. Meeks discusses expression-based subtypes for defining pathologic response to neoadjuvant ICIs in patients with MIBC.
The UromigosThe Uromigos | May 9, 2023
We discuss new data in bladder cancer and more presented at the 2023 American Urological Association Annual Meeting.
The UromigosThe Uromigos | May 3, 2023
An ODAC meeting determined that olaparib plus abiraterone for mCRPC should be restricted to patients with BRCA mutations.
The UromigosThe Uromigos | April 25, 2023
Dr. Daniel Heng joins us to discuss IMDC classification for RCC and the treatment of patients with favorable risk disease.
The UromigosThe Uromigos | April 21, 2023
Amar Kishan, MD, discusses his recent meta-analysis on the effects of concurrent neoadjuvant versus adjuvant sequencing.
The UromigosThe Uromigos | April 18, 2023
The latest topics in urologic oncology are discussed at the 14th International Uro-Oncology Conference in Brazil.
The UromigosThe Uromigos | April 17, 2023
Toni Choueiri, MD, and Brian Shuch, MD, discuss several studies on the use of belzutifan in patients with renal cancer.
The UromigosThe Uromigos | April 7, 2023
Ursula Vogl, MD, discusses her research and career progression in the prostate and renal cell cancer fields.
The UromigosThe Uromigos | March 28, 2023
Sia Daneshmand, MD, reviews 2 studies on the use of erdafitinib for the treatment of NMIBC, including the THOR-2 trial.
The UromigosThe Uromigos | March 22, 2023
The Uromigos are joined by Kala Sridhar, MD, to discuss the PET MUSE study on the impact of PET imaging in MIUC.
The UromigosThe Uromigos | March 17, 2023
Karine Tawagi, MD, from the University of Illinois, discusses her work in immune-related toxicities.
The UromigosThe Uromigos | March 7, 2023
Michiel Van der Heijden, MD, PhD, joined The Uromigos to review bladder cancer research from the 2023 ASCO GU Symposium.
The UromigosThe Uromigos | February 27, 2023
The Uromigos review ASCO GU 2023 data, including triplet vs doublet therapy, the ARASENS trial, and the ZIRCON phase 3 trial.
The UromigosThe Uromigos | February 21, 2023
Matt Galsky, MD discusses updates for the CheckMate 274 Trial at the 2023 ASCO GU Cancers Symposium with The Uromigos.
The UromigosThe Uromigos | February 21, 2023
Brian Shuch, MD, discusses the ZIRCON Phase III imaging study on identification and characterization abilities of TLX250-CDx.
The UromigosThe Uromigos | February 21, 2023
Christian Kollmannsberger, MD, FRCPC, discusses his presentation on utilizing miR371 as a biomarker for germ cell tumors.
The UromigosThe Uromigos | February 18, 2023
Neeraj Agarwal, MD, FASCO, describes positive data from the TALAPRO-2 study on talazoparib and enzalutamide for mCRPC.